Bridging chemical and biological space: "target fishing" using 2D and 3D molecular descriptors.
暂无分享,去创建一个
Z. Deng | A. Bender | J. Jenkins | M. Glick | J. Davies | J. Nettles
[1] John M. Barnard,et al. Clustering of chemical structures on the basis of two-dimensional similarity measures , 1992, J. Chem. Inf. Comput. Sci..
[2] L Zhang,et al. Synthesis and structure-activity relationships of novel retinoid X receptor-selective retinoids. , 1994, Journal of medicinal chemistry.
[3] J. Katzenellenbogen,et al. Synthesis, antitubulin and antimitotic activity, and cytotoxicity of analogs of 2-methoxyestradiol, an endogenous mammalian metabolite of estradiol that inhibits tubulin polymerization by binding to the colchicine binding site. , 1995, Journal of medicinal chemistry.
[4] P. Chambon. A decade of molecular biology of retinoic acid receptors , 1996, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.
[5] Yvonne C. Martin,et al. The Information Content of 2D and 3D Structural Descriptors Relevant to Ligand-Receptor Binding , 1997, J. Chem. Inf. Comput. Sci..
[6] P B Sigler,et al. Crystallographic comparison of the estrogen and progesterone receptor's ligand binding domains. , 1998, Proceedings of the National Academy of Sciences of the United States of America.
[7] David A. Agard,et al. The Structural Basis of Estrogen Receptor/Coactivator Recognition and the Antagonism of This Interaction by Tamoxifen , 1998, Cell.
[8] Nguyen-Huu Xuong,et al. Crystal structure of the potent natural product inhibitor balanol in complex with the catalytic subunit of cAMP-dependent protein kinase. , 1999 .
[9] D R Flower,et al. Lead generation using pharmacophore mapping and three-dimensional database searching: application to muscarinic M(3) receptor antagonists. , 1999, Journal of medicinal chemistry.
[10] Hans Matter,et al. Comparing 3D Pharmacophore Triplets and 2D Fingerprints for Selecting Diverse Compound Subsets , 1999, J. Chem. Inf. Comput. Sci..
[11] Ajay N. Jain. Morphological similarity: A 3D molecular similarity method correlated with protein-ligand recognition , 2000, J. Comput. Aided Mol. Des..
[12] Y.Z. Chen,et al. Ligand–protein inverse docking and its potential use in the computer search of protein targets of a small molecule , 2001, Proteins.
[13] G. Makara,et al. Measuring molecular similarity and diversity: total pharmacophore diversity. , 2001, Journal of medicinal chemistry.
[14] Robert P Sheridan,et al. Why do we need so many chemical similarity search methods? , 2002, Drug discovery today.
[15] R. Evans,et al. The Structural Basis for the Specificity of Retinoid-X Receptor-selective Agonists: New Insights Into the Role of Helix H12* , 2002, The Journal of Biological Chemistry.
[16] Paul W. Erhardt,et al. Medicinal chemistry in the new millennium. A glance into the future , 2002 .
[17] D. Moras,et al. Molecular recognition of agonist ligands by RXRs. , 2002, Molecular endocrinology.
[18] M. D. Leibowitz,et al. Design, synthesis, and structure-activity relationship studies of novel 6,7-locked-[7-(2-alkoxy-3,5-dialkylbenzene)-3-methylocta]-2,4,6-trienoic acids. , 2003, Journal of medicinal chemistry.
[19] V. Jordan,et al. The biological role of estrogen receptors α and β in cancer , 2004 .
[20] J. Jenkins,et al. A 3D similarity method for scaffold hopping from known drugs or natural ligands to new chemotypes. , 2004, Journal of medicinal chemistry.
[21] Andreas Bender,et al. Molecular Similarity Searching Using Atom Environments, Information-Based Feature Selection, and a Naïve Bayesian Classifier , 2004, J. Chem. Inf. Model..
[22] S. Ekins. Predicting undesirable drug interactions with promiscuous proteins in silico. , 2004, Drug discovery today.
[23] Andrew C. Good,et al. Descriptors you can count on? Normalized and filtered pharmacophore descriptors for virtual screening , 2004, J. Comput. Aided Mol. Des..
[24] R. Glen,et al. Molecular similarity: a key technique in molecular informatics. , 2004, Organic & biomolecular chemistry.
[25] B. Stockwell. Exploring biology with small organic molecules , 2004, Nature.
[26] Brian K. Shoichet,et al. Virtual screening of chemical libraries , 2004, Nature.
[27] Robert J. Jilek,et al. "Lead hopping". Validation of topomer similarity as a superior predictor of similar biological activities. , 2004, Journal of medicinal chemistry.
[28] Anthony Nicholls,et al. Variable selection and model validation of 2D and 3D molecular descriptors> , 2004, J. Comput. Aided Mol. Des..
[29] Andrew C. Good,et al. Measuring CAMD technique performance: A virtual screening case study in the design of validation experiments , 2004, J. Comput. Aided Mol. Des..
[30] Jérôme Hert,et al. Comparison of Fingerprint-Based Methods for Virtual Screening Using Multiple Bioactive Reference Structures , 2004, J. Chem. Inf. Model..
[31] J. A. Grant,et al. A shape-based 3-D scaffold hopping method and its application to a bacterial protein-protein interaction. , 2005, Journal of medicinal chemistry.
[32] M. Austen,et al. Phenotype-first screening for the identification of novel drug targets. , 2005, Drug discovery today.
[33] Tudor I. Oprea,et al. WOMBAT: World of Molecular Bioactivity , 2005 .
[34] Qiang Zhang,et al. Scaffold hopping through virtual screening using 2D and 3D similarity descriptors: ranking, voting, and consensus scoring. , 2006, Journal of medicinal chemistry.
[35] G. Schneider,et al. Scaffold‐Hopping Potential of Ligand‐Based Similarity Concepts , 2006, ChemMedChem.
[36] Meir Glick,et al. Prediction of Biological Targets for Compounds Using Multiple-Category Bayesian Models Trained on Chemogenomics Databases , 2006, J. Chem. Inf. Model..
[37] Ajay N. Jain,et al. Robust ligand-based modeling of the biological targets of known drugs. , 2006, Journal of medicinal chemistry.
[38] A. Bender,et al. Circular fingerprints: flexible molecular descriptors with applications from physical chemistry to ADME. , 2006, IDrugs : the investigational drugs journal.
[39] P. Chambon,et al. Function of retinoid nuclear receptors: lessons from genetic and pharmacological dissections of the retinoic acid signaling pathway during mouse embryogenesis. , 2006, Annual review of pharmacology and toxicology.
[40] Andreas Bender,et al. "Bayes Affinity Fingerprints" Improve Retrieval Rates in Virtual Screening and Define Orthogonal Bioactivity Space: When Are Multitarget Drugs a Feasible Concept? , 2006, J. Chem. Inf. Model..